RXDX Annual CFF
$562.20 M
+$294.51 M+110.02%
31 December 2022
Summary:
As of February 5, 2025, RXDX annual cash flow from financing activities is $562.20 million, with the most recent change of +$294.51 million (+110.02%) on December 31, 2022. During the last 3 years, it has risen by +$552.45 million (+5663.22%).RXDX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RXDX Quarterly CFF
$52.80 M
-$422.54 M-88.89%
31 March 2023
Summary:
As of February 5, 2025, RXDX quarterly cash flow from financing activities is $52.80 million, with the most recent change of -$422.54 million (-88.89%) on March 31, 2023. Over the past year, it has increased by +$52.68 million (+42826.02%).RXDX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RXDX TTM CFF
$614.88 M
+$52.68 M+9.37%
31 March 2023
Summary:
As of February 5, 2025, RXDX TTM cash flow from financing activities is $614.88 million, with the most recent change of +$52.68 million (+9.37%) on March 31, 2023. Over the past year, it has increased by +$623.38 million (+7329.61%).RXDX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RXDX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +110.0% | +10000.0% | +7329.6% |
| 3 y3 years | +5663.2% | +49.5% | +1641.5% |
| 5 y5 years | +5663.2% | +49.5% | +1641.5% |
RXDX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -88.9% | at high |
Prometheus Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $52.80 M(-88.9%) | $614.88 M(+9.4%) |
| Dec 2022 | $562.20 M(+110.0%) | $475.33 M(+559.2%) | $562.20 M(+543.5%) |
| Sept 2022 | - | $72.11 M(+392.7%) | $87.37 M(+1091.5%) |
| June 2022 | - | $14.63 M(>+9900.0%) | $7.33 M(-186.2%) |
| Mar 2022 | - | $123.00 K(-75.6%) | -$8.51 M(-103.2%) |
| Dec 2021 | $267.69 M | $505.00 K(-106.4%) | $267.69 M(-14.4%) |
| Sept 2021 | - | -$7.93 M(+559.2%) | $312.70 M(-2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$1.20 M(-100.4%) | $319.62 M(-0.4%) |
| Mar 2021 | - | $276.32 M(+507.1%) | $320.90 M(+301.7%) |
| Dec 2020 | $79.89 M(+718.9%) | $45.52 M(-4584.2%) | $79.89 M(+132.4%) |
| Sept 2020 | - | -$1.01 M(-1401.3%) | $34.37 M(-2.9%) |
| June 2020 | - | $78.00 K(-99.8%) | $35.39 M(+0.2%) |
| Mar 2020 | - | $35.31 M | $35.31 M |
| Dec 2019 | $9.76 M | - | - |
FAQ
- What is Prometheus Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Prometheus Biosciences?
- What is Prometheus Biosciences annual CFF year-on-year change?
- What is Prometheus Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Prometheus Biosciences?
- What is Prometheus Biosciences quarterly CFF year-on-year change?
- What is Prometheus Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Prometheus Biosciences?
- What is Prometheus Biosciences TTM CFF year-on-year change?
What is Prometheus Biosciences annual cash flow from financing activities?
The current annual CFF of RXDX is $562.20 M
What is the all time high annual CFF for Prometheus Biosciences?
Prometheus Biosciences all-time high annual cash flow from financing activities is $562.20 M
What is Prometheus Biosciences annual CFF year-on-year change?
Over the past year, RXDX annual cash flow from financing activities has changed by +$294.51 M (+110.02%)
What is Prometheus Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of RXDX is $52.80 M
What is the all time high quarterly CFF for Prometheus Biosciences?
Prometheus Biosciences all-time high quarterly cash flow from financing activities is $475.33 M
What is Prometheus Biosciences quarterly CFF year-on-year change?
Over the past year, RXDX quarterly cash flow from financing activities has changed by +$52.68 M (+42826.02%)
What is Prometheus Biosciences TTM cash flow from financing activities?
The current TTM CFF of RXDX is $614.88 M
What is the all time high TTM CFF for Prometheus Biosciences?
Prometheus Biosciences all-time high TTM cash flow from financing activities is $614.88 M
What is Prometheus Biosciences TTM CFF year-on-year change?
Over the past year, RXDX TTM cash flow from financing activities has changed by +$623.38 M (+7329.61%)